Comparative Effectiveness Analysis Recent meta-analyses have provided insights into the relative effectiveness of different GLP-1 agonists
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
[91] observe that brain KBs and blood glucose are inversely correlated such that a systemic drop in blood sugar (in part due to increased uptake into the brain), is associated with increased systemic production and cerebral uptake of KBs
Biden TJ, Boslem E, Chu KY, Sue N
Learn more about the SmithRx Weight Management Program: #ModernPBM #BenefitsLeaders #CHRO #HR #GLP1s #SmithRx Love our partner ecosystem
A licensed provider can help determine whether treatment is appropriate based on your individual history and symptoms